Highlight Capital
Venture capitalNanjin · Seed–Series B
Find your way into Highlight Capital
Investment thesis
Highlight Capital positions itself around professionalism, stability, and innovation, focusing on deep, long-term investing in China. Over more than ten years it has built a portfolio of over 200 companies, with a notable emphasis on healthcare and life sciences (biotech, pharmaceuticals) as suggested by recent portfolio activity. The firm has achieved 30+ IPOs, indicating a track record spanning early through later stages of company development in the Chinese market.
Source: firm website, verified Aug 3, 2026.
What founders say
No founder feedback on Highlight Capital yet.
What they invest in
from 18 of 40 portfolio companiesHealthtech ×13Biotech ×10Medical Devices ×8Hardware ×7Deep Tech ×4Digital Health ×4Advanced Manufacturing ×3Semiconductors ×3
HQs:China×7United States×4Germany×1Singapore×1
Investments · 40 tracked
founders shown can be your intro pathBy year:2025 · 12020 · 12019 · 22017 · 15 dated
T-CURX is a venture-backed biotechnology company developing autologous CAR-T cell therapies using proprietary non-viral technologies, including in vivo and bedside-manufactured CAR-T approaches based on T cell-targeted LNP delivery of Sleeping Beauty transposon vectors.
BiotechHealthtechWürzburg, DE
Michael Hudecek(Co-founder)Christoph Rader(Co-founder & Member of the Scientific Advisory Board)Ulf Grawunder(Co-founder & CEO)in
Co-investorsBioMedPartnersi&i Biotech Fund
Abogen Biosciences is a clinical-stage biotechnology company developing RNA-based medicines, with in-house capabilities spanning the full mRNA drug development cycle including protein engineering, mRNA sequence design and synthesis, lipid nanoparticle delivery, formulation, and commercial-scale manufacturing.
BiotechDeep TechHealthtech
Co-investorsCoatue ManagementMorningside Venture Capital LimitedQiming Venture PartnersSoftBank Vision FundBoyu CapitalGL Ventures+6 more
Arthrosi Therapeutics is a clinical-stage biopharmaceutical company developing treatments for gout, an inflammatory arthritis condition.
BiotechDigital HealthMedical DevicesSan Diego, US
Litain Yeh(Co-Founder & Chief Executive Officer)inShunqi Yan(Co-Founder & Chief Operating Officer)Robert Orr(Executive Officer, Director, Promoter)Yiwei Zong(Director)Jianfeng Fang(Director)
BoardZhang Mingyuan(Director)
Co-investorsHM Venture Partners
A pharmaceutical company that develops medicines and vaccines, with research pipelines and clinical trials aimed at new treatments.
BiotechHealthtech
Co-investorsFrazier Life SciencesMRL Ventures FundXeraya CapitalAmgen VenturesBlackRockBlackstone Life Sciences+5 more
MCT manufactures satellite positioning and GNSS evaluation kits for automotive and robotics applications, featuring tri-band RTK receivers with automotive-grade certifications for operation in extreme temperatures.
AI & Machine LearningDeep TechHardwareRoboticsSemiconductorsChangzhou, CN
Nuevocor is a biotechnology company developing gene therapy treatments for cardiovascular and metabolic diseases.
BiotechDigital HealthHealthtechMedical DevicesSingapore, SG
Brian Burke(Co-Founder and Advisor)inMark Kay(Co-Founder and Advisor)Colin Stewart(Co-Founder and Advisor)Yann Chong Tan(Co-Founder and Advisor)inMonica Shah(Chief Medical Officer)inAl Gianchetti(Chief Executive Officer)in
Co-investorsAngelini VenturesKurma PartnersBoehringer Ingelheim Venture FundClavystBioSEEDS Capital
Verseau Therapeutics discovers and develops macrophage-targeting monoclonal antibodies to enhance anti-tumor immune responses in cancer patients.
AI & Machine LearningBiotechHealthtechMedical DevicesAuburndale, US
Bob Langer(Director, Promoter)Dan Anderson(Executive Officer, Director, Promoter)inTatiana NovobrantsevainIgor FeldmaninWalter Capone(Executive Officer)Christine Bunt(Executive Officer, Director)in
Co-investors20/20 HealthCare Partners LLCYonghua Capital
WuXi AppTec is a global Contract Research, Development and Manufacturing Organization (CRDMO) that provides integrated drug development services spanning chemistry, biology discovery, preclinical testing, and clinical research across Asia, Europe, and North America.
Advanced ManufacturingBiotechEnterprise SoftwareHealthtech
Co-investorsHuangpu River CapitalVivo CapitalLegend Capital
Zentalis is a biopharmaceutical company developing azenosertib and other pipeline assets, seeking strategic partnerships to advance drug development and expand market reach globally.
BiotechHealthtechMedical Devices
Julie Eastland(Chief Executive Officer and Director)in
BoardScott Myers(Chairperson)
Co-investorsDecheng Capital
Shanghai General Healthy Information & Technology develops intelligent medical logistics and automation equipment, including automated pharmacy dispensing systems marketed under the CONSIS and SANTO brands, for hospitals.
Digital HealthHardwareHealthtechRoboticsShanghai, CN
Pharmaron provides drug research and development services globally, supporting the discovery and development of pharmaceutical therapies through integrated capabilities across multiple geographic regions.
Advanced ManufacturingBiotechDeep TechEnterprise SoftwareHealthtechMedical DevicesBeijing, CN
楼柏良(董事长兼首席执行官 (Chairman & CEO))Lou Bailiang(Chemist, Chairman & CEO)
Co-investorsLegend Capital
Zylox-Tonbridge Medical is a Chinese medical device company developing clinical solutions and products, with a focus on neurovascular and peripheral vascular interventional treatments.
HardwareHealthtechMedical DevicesHangzhou, CN
Smoore is an atomization technology company that develops and manufactures vaping and electronic atomization devices.
Advanced ManufacturingHardware
Tigermed is a contract research organization (CRO) offering full-service clinical development support to the global biopharmaceutical and medical device industries, covering small molecules, biologics, vaccines, and medical devices.
BiotechDigital HealthHealthtechMedical DevicesHangzhou, CN
Co-investorsQiming Venture Partners
Chinese fabless semiconductor company developing enterprise-grade interconnect chips, including PCIe interface chips, memory interface chips and buffers, network interface chips, and clock/general interface chips.
Deep TechHardwareSemiconductorsChengdu, CN
Drug discovery services (01873.HK)
Medical device company (002223.SZ)
KK Chips designs automotive semiconductor solutions including power management, driver, and control chips for 12V and 24V automotive systems used in electric vehicles, hybrid vehicles, and commercial vehicles.
HardwareMobility & TransportationSemiconductorsGuangzhou, CN
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
GaushImago BioSciences, Inc.上海君屹亚电科技凯因科技剂泰科技千寻智能华夏英泰博瑞医药圣湘生物拓烯科技星能玄光百洋医药科美诊断科辉智药药明康德蓝色向量逻辑比特长江存储高视医疗
Exits · 1
1 acquisitionsImagoacq. by Merck
Portfolio news
latest coverage across their companies
Zentalis · biospace.com · Aug 14, 2026
T-CURX · uni-wuerzburg.de · Dec 17, 2025
Arthrosi · finsmes.com · Oct 8, 2025
Frequently asked questions
- How many investments has Highlight Capital made?
- Highlight Capital has 40 tracked investments, 1 of which have exited, including 1 dated in the last 24 months.
- What stage does Highlight Capital invest at?
- Highlight Capital invests at the Seed, Series A, Series B stages.
- What is Highlight Capital's typical check size?
- Highlight Capital typically writes checks of $2.8M – $74M.
- What sectors does Highlight Capital focus on?
- Highlight Capital focuses on Biotech, Crypto & Web3, Healthtech.
- Where is Highlight Capital located?
- Highlight Capital is headquartered in Nanjin, CN.
- Who does Highlight Capital co-invest with?
- Highlight Capital most often shares deals with LAV, OrbiMed, Qiming Venture Partners, among 10 tracked co-investors.
Similar investors
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Bessemer Venture Partners is a global venture capital firm that partners with entrepreneurs across enterprise, consumer, and healthcare sectors from early stages through growth.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Index Ventures is a venture capital firm that backs founders across industries and geographies, emphasizing the people behind ideas as much as the businesses themselves.




























.jpeg)

